Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.
- Author:
Haidong XU
1
;
Chungyoul CHOE
;
Seung Hun SHIN
;
Sung Won PARK
;
Ho Shik KIM
;
Seung Hyun JUNG
;
Seon Hee YIM
;
Tae Min KIM
;
Yeun Jun CHUNG
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: cell cycle; cytokinesis; hepatocellular carcinoma; KIF14; p27(kip1); ubiquitination
- MeSH: Carcinoma, Hepatocellular/*metabolism; Cyclin-Dependent Kinase Inhibitor p27/genetics/*metabolism; Cyclins/genetics/metabolism; *Cytokinesis; Gene Silencing; Hep G2 Cells; Humans; Kinesin/genetics/*metabolism; Liver Neoplasms/*metabolism; Oncogene Proteins/genetics/*metabolism; Proteasome Endopeptidase Complex/metabolism; RNA, Messenger/genetics/metabolism; S-Phase Kinase-Associated Proteins/genetics/metabolism; *Ubiquitination
- From:Experimental & Molecular Medicine 2014;46(5):e97-
- CountryRepublic of Korea
- Language:English
- Abstract: Although it has been suggested that kinesin family member 14 (KIF14) has oncogenic potential in various cancers, including hepatocellular carcinoma (HCC), the molecular mechanism of this potential remains unknown. We aimed to elucidate the role of KIF14 in hepatocarcinogenesis by knocking down KIF14 in HCC cells that overexpressed KIF14. After KIF14 knockdown, changes in tumor cell growth, cell cycle and cytokinesis were examined. We also examined cell cycle regulatory molecules and upstream Skp1/Cul1/F-box (SCF) complex molecules. Knockdown of KIF14 resulted in suppression of cell proliferation and failure of cytokinesis, whereas KIF14 overexpression increased cell proliferation. In KIF14-silenced cells, the levels of cyclins E1, D1 and B1 were profoundly decreased compared with control cells. Of the cyclin-dependent kinase inhibitors, the p27Kip1 protein level specifically increased after KIF14 knockdown. The increase in p27Kip1 was not due to elevation of its mRNA level, but was due to inhibition of the proteasome-dependent degradation pathway. To explore the pathway upstream of this event, we measured the levels of SCF complex molecules, including Skp1, Skp2, Cul1, Roc1 and Cks1. The levels of Skp2 and its cofactor Cks1 decreased in the KIF14 knockdown cells where p27Kip1 accumulated. Overexpression of Skp2 in the KIF14 knockdown cells attenuated the failure of cytokinesis. On the basis of these results, we postulate that KIF14 knockdown downregulates the expression of Skp2 and Cks1, which target p27Kip1 for degradation by the 26S proteasome, leading to accumulation of p27Kip1. The downregulation of Skp2 and Cks1 also resulted in cytokinesis failure, which may inhibit tumor growth. To the best of our knowledge, this is the first report that has identified the molecular target and oncogenic effect of KIF14 in HCC.
